Statistics
Publications
20
Citations
1.3K
H-Index
15
Active since
2013
Thomas E. Lew is an author at The University of Melbourne specializing in medicine, chronic lymphocytic leukemia therapy, and molecular oncology.
Publications per year
2013–2025
20
20
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax
Victor S. Lin, Thomas E. Lew, Sasanka M. Handunnetti et al. · Blood · 2020 · 87 citations · Full text
1–5 of 20